Published Online
on May 3, 2004

A more recent version of this article appeared on May 25, 2004

This Article Full Text (PDF) All Versions of this Article: 109/20/2423    most recent 01.CIR.0000129414.95137.CDv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lazar, R. M. Articles by Naka, Y. Search for Related Content PubMed PubMed Citation Articles by Lazar, R. M. Articles by Naka, Y. Pubmed/NCBI databases Medline Plus Health Information Heart Failure Stroke Related Collections Health policy and outcome research Congestive CV surgery: transplantation, ventricular assistance, cardiomyopathy Embolic stroke

Submitted on October 28, 2003
Revised on February 19, 2004
Accepted on February 25, 2004

Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure. The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Experience

Ronald M. Lazar PhD^*, Peter A. Shapiro MD, Brian E. Jaski MD, Michael K. Parides PhD, Robert C. Bourge MD, John T. Watson PhD, Laura Damme RN, MPH, Walter Dembitsky MD, Jeffrey D. Hosenpud MD, Lopa Gupta RD, MPH, Anita Tierney MPH, Tonya Kraus RN, MSN, and Yoshifumi Naka MD

From the Departments of Neurology (R.M.L.), Psychiatry (P.A.S.), Biostatistics (M.K.P.), and Surgery (L.G., A.T., Y.N.), Columbia University College of Physicians and Surgeons, New York, NY; the Advanced Heart Failure and Cardiac Transplant Program (B.E.J., W.D.), Sharp Memorial Hospital, San Diego, Calif; the Division of Cardiovascular Disease (R.C.B.), University of Alabama at Birmingham; the Department of Bioengineering (J.T.W.), University of California San Diego; Thoratec Corp, Pleasanton, Calif (L.D.); the Organ Transplant Program (J.E.H.), St Luke’s Medical Center, Milwaukee, Wis; and Inova Fairfax Hospital, Fairfax, Va (T.K.).

^* To whom correspondence should be addressed. E-mail: ral22{at}columbia.edu.

Background--Progression of heart failure can lead to cardiac transplantation, but when patients are ineligible, long-term mechanical circulatory support may improve survival. The REMATCH trial showed that left ventricular assist devices (LVADs) prolonged survival in patients with end-stage disease, but with a significant number of adverse events. We report on the neurological outcomes in the REMATCH trial.

Methods and Results--We examined new neurological events in the 129 patients randomized to either LVAD placement (n=68) or medical management (n=61), classified as stroke, transient ischemic attack, toxic-metabolic encephalopathy, and other. There were 46 neurological events: 42 in 30 LVAD patients and 4 in 4 patients in the medical arm (², 30/68 versus 4/61, P<0.001). Sixteen percent of the LVAD patients had a stroke, with a rate of 0.19 per year (95% CI, 0.10 to 0.33), many occurring in the postoperative period. The stroke rate in the medical arm was 0.052. A Kaplan-Meier survival analysis showed a 44% reduction in the risk of stroke or death in the LVAD group versus the optimal medical group (P=0.002). The mean interval from implantation to stroke was 221.8 days (±70.4 days). History of stroke, age, and sepsis were not stroke risk factors in the LVAD group.

Conclusions--Fewer than half of the patients in the LVAD group had a neurological event, and there were few neurological deaths. Survival analysis combining stroke or death demonstrated a significant benefit for long-term circulatory support with an LVAD over medical therapy. Future trials will need to address prospectively all neurological outcomes, including neurocognitive function, and the role of long-term neuroprotection.

Key words: heart-assist device • stroke • heart failure

This article has been cited by other articles:

				S. R. Wilson, M. M. Givertz, G. C. Stewart, and G. H. Mudge Jr Ventricular assist devices the challenges of outpatient management. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1647 - 1659. [Abstract] [Full Text] [PDF]

				K. Lietz, K. Brown, S. S. Ali, M. Colvin-Adams, A. J. Boyle, D. Anderson, A. D. Weinberg, L. W. Miller, S. Park, R. John, et al. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 1012 - 1019. [Abstract] [Full Text] [PDF]

				J. W. Long, A. H. Healy, B. Y. Rasmusson, C. G. Cowley, K. E. Nelson, A. G. Kfoury, S. E. Clayson, B. B. Reid, S. A. Moore, D. U. Blank, et al. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1353 - 1361. [Abstract] [Full Text] [PDF]

				J. G. Rogers, J. Butler, S. L. Lansman, A. Gass, P. M. Portner, M. K. Pasque, R. N. Pierson III, and for the INTrEPID Investigators Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates: Results of the INTrEPID Trial J. Am. Coll. Cardiol., August 21, 2007; 50(8): 741 - 747. [Abstract] [Full Text] [PDF]

				H. Tsukui, A. Abla, J. J. Teuteberg, D. M. McNamara, M. A. Mathier, L. M. Cadaret, and R. L. Kormos Cerebrovascular accidents in patients with a ventricular assist device J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 114 - 123. [Abstract] [Full Text] [PDF]

				B. L. Steenwyk, J. K. Kirklin, W. Q. Gurley, and V. G. Nielsen The Hemostatic History of a 15-Month-Old Child Implanted with a Berlin Heart Left Ventricular Assist Device Anesth. Analg., March 1, 2007; 104(3): 538 - 540. [Abstract] [Full Text] [PDF]

				L. W. Stevenson and P. Shekar Ventricular Assist Devices for Durable Support Circulation, August 30, 2005; 112(9): e111 - e115. [Full Text] [PDF]

				Other articles noted Evid. Based Med., September 1, 2004; 9(5): e5 - e5. [Full Text] [PDF]